Literature DB >> 33374806

Beta-Arrestins and Receptor Signaling in the Vascular Endothelium.

Claudia Lee1, Gayathri Viswanathan2, Issac Choi2, Chanpreet Jassal3, Taylor Kohlmann4, Sudarshan Rajagopal1,2.   

Abstract

The vascular endothelium is the innermost layer of blood vessels and is a key regulator of vascular tone. Endothelial function is controlled by receptor signaling through G protein-coupled receptors, receptor tyrosine kinases and receptor serine-threonine kinases. The β-arrestins, multifunctional adapter proteins, have the potential to regulate all of these receptor families, although it is unclear as to whether they serve to integrate signaling across all of these different axes. Notably, the β-arrestins have been shown to regulate signaling by a number of receptors important in endothelial function, such as chemokine receptors and receptors for vasoactive substances such as angiotensin II, endothelin-1 and prostaglandins. β-arrestin-mediated signaling pathways have been shown to play central roles in pathways that control vasodilation, cell proliferation, migration, and immune function. At this time, the physiological impact of this signaling has not been studied in detail, but a deeper understanding of it could lead to the development of novel therapies for the treatment of vascular disease.

Entities:  

Keywords:  G protein-coupled receptor; beta-arrestin; chemokine receptors; receptor serine-threonine kinases, vascular endothelial growth factor receptor (VEGFR); receptor tyrosine kinases; type II bone morphogenetic protein receptor (BMPR-II)

Mesh:

Substances:

Year:  2020        PMID: 33374806      PMCID: PMC7824595          DOI: 10.3390/biom11010009

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  124 in total

1.  Meningococcus Hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature endothelium.

Authors:  Mathieu Coureuil; Hervé Lécuyer; Mark G H Scott; Cédric Boularan; Hervé Enslen; Magali Soyer; Guillain Mikaty; Sandrine Bourdoulous; Xavier Nassif; Stefano Marullo
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

Review 2.  Effects of endocytosis on receptor-mediated signaling.

Authors:  Roshanak Irannejad; Nikoleta G Tsvetanova; Braden T Lobingier; Mark von Zastrow
Journal:  Curr Opin Cell Biol       Date:  2015-06-06       Impact factor: 8.382

3.  Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4.

Authors:  Xianlong Gao; You-Hong Cheng; Garrett A Enten; Anthony J DeSantis; Vadim Gaponenko; Matthias Majetschak
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

4.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Authors:  Sébastien Ferrandon; Timothy N Feinstein; Marian Castro; Bin Wang; Richard Bouley; John T Potts; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

5.  IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain.

Authors:  Richard J Bodnar; Cecelia C Yates; Alan Wells
Journal:  Circ Res       Date:  2006-02-16       Impact factor: 17.367

6.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

7.  Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin.

Authors:  Kelly N Nobles; Kunhong Xiao; Seungkirl Ahn; Arun K Shukla; Christopher M Lam; Sudarshan Rajagopal; Ryan T Strachan; Teng-Yi Huang; Erin A Bressler; Makoto R Hara; Sudha K Shenoy; Steven P Gygi; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2011-08-09       Impact factor: 8.192

8.  CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.

Authors:  Lillian Cruz-Orengo; David W Holman; Denise Dorsey; Liang Zhou; Penglie Zhang; Melissa Wright; Erin E McCandless; Jigisha R Patel; Gary D Luker; Dan R Littman; John H Russell; Robyn S Klein
Journal:  J Exp Med       Date:  2011-02-07       Impact factor: 14.307

Review 9.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 10.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

View more
  2 in total

1.  Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway.

Authors:  Huifen Zhou; Yu He; Jiaqi Zhu; Xiaojie Lin; Juan Chen; Chongyu Shao; Haitong Wan; Jiehong Yang
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

2.  MiR-550a-3p restores damaged vascular smooth muscle cells by inhibiting thrombomodulin in an <em>in vitro</em> atherosclerosis model.

Authors:  Shiyuan Chen; Longfei Zhang; Benchi Feng; Wei Wang; Delang Liu; Xinyu Zhao; Chaowen Yu; Xiaogao Wang; Yong Gao
Journal:  Eur J Histochem       Date:  2022-07-19       Impact factor: 1.966

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.